These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 10873620
1. Losartan inhibits cellular uptake of oxidized LDL by monocyte-macrophages from hypercholesterolemic patients. Hayek T, Aviram M, Heinrich R, Sakhnini E, Keidar S. Biochem Biophys Res Commun; 2000 Jul 05; 273(2):417-20. PubMed ID: 10873620 [Abstract] [Full Text] [Related]
2. Angiotensin II injection into mice increases the uptake of oxidized LDL by their macrophages via a proteoglycan-mediated pathway. Keidar S, Attias J. Biochem Biophys Res Commun; 1997 Oct 09; 239(1):63-7. PubMed ID: 9345270 [Abstract] [Full Text] [Related]
3. Angiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized ldl: a possible role for interleukin-6. Keidar S, Heinrich R, Kaplan M, Hayek T, Aviram M. Arterioscler Thromb Vasc Biol; 2001 Sep 09; 21(9):1464-9. PubMed ID: 11557673 [Abstract] [Full Text] [Related]
4. Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages. Fuhrman B, Volkova N, Aviram M. J Nutr Biochem; 2005 Sep 09; 16(9):570-6. PubMed ID: 16115546 [Abstract] [Full Text] [Related]
5. Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes. Fuhrman B, Koren L, Volkova N, Keidar S, Hayek T, Aviram M. Atherosclerosis; 2002 Sep 09; 164(1):179-85. PubMed ID: 12119208 [Abstract] [Full Text] [Related]
6. Serotonin increases macrophage uptake of oxidized low density lipoprotein. Aviram M, Fuhrman B, Maor I, Brook GJ. Eur J Clin Chem Clin Biochem; 1992 Feb 09; 30(2):55-61. PubMed ID: 1581411 [Abstract] [Full Text] [Related]
7. Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation. Mehta JL, Hu B, Chen J, Li D. Arterioscler Thromb Vasc Biol; 2003 Dec 09; 23(12):2203-8. PubMed ID: 12958047 [Abstract] [Full Text] [Related]
8. Effects of lycopene on the induction of foam cell formation by modified LDL. Napolitano M, De Pascale C, Wheeler-Jones C, Botham KM, Bravo E. Am J Physiol Endocrinol Metab; 2007 Dec 09; 293(6):E1820-7. PubMed ID: 17911344 [Abstract] [Full Text] [Related]
9. Intraperitoneal injection of platelet secretory products into mice increases macrophage uptake of oxidized low density lipoprotein. Hussein O, Brook GJ, Aviram M. Isr J Med Sci; 1993 Aug 09; 29(8):453-9. PubMed ID: 8407271 [Abstract] [Full Text] [Related]
10. Upregulation of LOX-1 expression in aorta of hypercholesterolemic rabbits: modulation by losartan. Chen H, Li D, Sawamura T, Inoue K, Mehta JL. Biochem Biophys Res Commun; 2000 Oct 05; 276(3):1100-4. PubMed ID: 11027596 [Abstract] [Full Text] [Related]
11. Sterol regulatory element binding proteins downregulate LDL receptor-related protein (LRP1) expression and LRP1-mediated aggregated LDL uptake by human macrophages. Llorente-Cortés V, Royo T, Otero-Viñas M, Berrozpe M, Badimon L. Cardiovasc Res; 2007 Jun 01; 74(3):526-36. PubMed ID: 17376415 [Abstract] [Full Text] [Related]
12. Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis. Keidar S, Attias J, Heinrich R, Coleman R, Aviram M. Atherosclerosis; 1999 Oct 01; 146(2):249-57. PubMed ID: 10532681 [Abstract] [Full Text] [Related]
13. The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice. Keidar S, Attias J, Smith J, Breslow JL, Hayek T. Biochem Biophys Res Commun; 1997 Jul 30; 236(3):622-5. PubMed ID: 9245700 [Abstract] [Full Text] [Related]
15. Atherosclerosis development in SLE patients is not determined by monocytes ability to bind/endocytose Ox-LDL. Yassin LM, Londoño J, Montoya G, De Sanctis JB, Rojas M, Ramírez LA, García LF, Vásquez G. Autoimmunity; 2011 May 30; 44(3):201-10. PubMed ID: 21231894 [Abstract] [Full Text] [Related]
16. Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy. Rosenblat M, Hayek T, Hussein K, Aviram M. Arterioscler Thromb Vasc Biol; 2004 Jan 30; 24(1):175-80. PubMed ID: 14592851 [Abstract] [Full Text] [Related]
17. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension. Sendra J, Llorente-Cortés V, Costales P, Huesca-Gómez C, Badimon L. Cardiovasc Res; 2008 Jun 01; 78(3):581-9. PubMed ID: 18281370 [Abstract] [Full Text] [Related]
18. Ceramides reduce CD36 cell surface expression and oxidised LDL uptake by monocytes and macrophages. Luan Y, Griffiths HR. Arch Biochem Biophys; 2006 Jun 01; 450(1):89-99. PubMed ID: 16620763 [Abstract] [Full Text] [Related]
19. Cholesteryl ester hydroperoxides increase macrophage CD36 gene expression via PPARalpha. Jedidi I, Couturier M, Thérond P, Gardès-Albert M, Legrand A, Barouki R, Bonnefont-Rousselot D, Aggerbeck M. Biochem Biophys Res Commun; 2006 Dec 22; 351(3):733-8. PubMed ID: 17084382 [Abstract] [Full Text] [Related]
20. Differences in LDL receptor-mediated metabolism of three low density lipoprotein subfractions by human monocyte-derived macrophages: impact on the risk for atherosclerosis. de Graaf J, Hendriks JC, Swinkels DW, Demacker PN, Stalenhoef AF. Artery; 1993 Dec 22; 20(4):201-30. PubMed ID: 8250739 [Abstract] [Full Text] [Related] Page: [Next] [New Search]